NCT04980170

Brief Summary

Among patients receiving dental implants, does the choice of antibiotics reduce the frequency of early implant failure ?

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Nov 2021

Shorter than P25 for early_phase_1

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 9, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 28, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

November 1, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2022

Completed
Last Updated

July 28, 2021

Status Verified

July 1, 2021

Enrollment Period

4 months

First QC Date

June 9, 2021

Last Update Submit

July 18, 2021

Conditions

Keywords

Effect of antiobiotic presctibed on early deental implant failure

Outcome Measures

Primary Outcomes (1)

  • Early failure of osseointegration of dental implants

    Failure of osseointegration is defined as having ANY ONE of the following during the first three months of implant placement. 1. implant mobility: Measured using two metal instruments moving against each other. 2. Acute surgical site infection: presence of erythema, swelling, pain, discharge at the site of implant. 3. Radiographic Bone Loss \>50% of implant length: measured using calibrated digital tool on peri-apical radiograph. 4. Pain on function: measured using a verbal analogue scale (VAS). Patients were asked to describe the amount of pain they felt by giving a number from 0 to 10, where 0 represented not feeling any sort of pain and 10 represented the maximum pain they could imagine.

    3 months

Study Arms (2)

clindamycin group

EXPERIMENTAL

Patients who take Clindamycin after Dental implants

Drug: Clindamycin 300 mg

Amoxicillin With Clavulanic Acid group

EXPERIMENTAL

Patients who take Amoxicillin With Clavulanic Acid after Dental implants

Drug: Amoxicillin with Clavulanic Acid 635mg

Interventions

patients will be given clindamycin 300 mg twice daily for 5 days after dental implant

Also known as: Clinacin
clindamycin group

patients will be given Amoxicillin with Clavulanic Acid 635mg, three times daily for 5 days after dental implant

Also known as: Augmentin
Amoxicillin With Clavulanic Acid group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Presence of a partial edentulous or edentulous alveolar ridge.
  • Presence of a tooth or several teeth regarded as non-restorable with the intention of immediate implant placement.
  • Periodontally healthy remaining dentition.
  • Presence of a non-infected surgical site.
  • Presence of enough bone and soft tissue for the implant to be placed without additional augmentation procedures.
  • Must be able to swallow tablets

You may not qualify if:

  • Patients with medical conditions that required antibiotic premedication such as prosthetic heart valve replacement, skeletal joint replacement, previous history of infective endocarditis and a history of rheumatic fever.
  • Patients with metabolic diseases such as type I or II diabetes mellitus.
  • Patients with past and present neoplastic disease.
  • Previous radiotherapy in the head and neck area.
  • Immunosuppressed patients.
  • Patients with blood coagulation impairment.
  • Patients with a history of systemic steroid medication or recent systemic antibiotic therapy.
  • Pregnant and lactating women
  • Patients with allergy to the antibiotic chosen.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Jordan Hospital

Amman, 11492, Jordan

Location

Related Publications (4)

  • Malm MO, Jemt T, Stenport VF. Patient factors related to early implant failures in the edentulous jaw: A large retrospective case-control study. Clin Implant Dent Relat Res. 2021 Jun;23(3):466-476. doi: 10.1111/cid.13009. Epub 2021 May 17.

  • Malm MO, Jemt T, Stenport V. Early Implant Failures in Edentulous Patients: A Multivariable Regression Analysis of 4615 Consecutively Treated Jaws. A Retrospective Study. J Prosthodont. 2018 Dec;27(9):803-812. doi: 10.1111/jopr.12985. Epub 2018 Oct 29.

  • De Bruyn H, Raes S, Ostman PO, Cosyn J. Immediate loading in partially and completely edentulous jaws: a review of the literature with clinical guidelines. Periodontol 2000. 2014 Oct;66(1):153-87. doi: 10.1111/prd.12040.

  • Baqain ZH, Moqbel WY, Sawair FA. Early dental implant failure: risk factors. Br J Oral Maxillofac Surg. 2012 Apr;50(3):239-43. doi: 10.1016/j.bjoms.2011.04.074. Epub 2011 May 25.

MeSH Terms

Interventions

ClindamycinAmoxicillinClavulanic AcidAmoxicillin-Potassium Clavulanate Combination

Intervention Hierarchy (Ancestors)

LincomycinLincosamidesPyrrolidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsGlycosidesCarbohydratesAmpicillinPenicillin GPenicillinsbeta-LactamsLactamsAmidesOrganic ChemicalsSulfur CompoundsHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingClavulanic AcidsDrug CombinationsPharmaceutical Preparations

Study Officials

  • ASHRAF ABUKARAKI, PROFESSOR

    Jordan University Hospital

    STUDY DIRECTOR

Central Study Contacts

ASHRAF ABUKARAKI, PROFESSOR

CONTACT

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Oral and Maxillofacial surgery resident

Study Record Dates

First Submitted

June 9, 2021

First Posted

July 28, 2021

Study Start

November 1, 2021

Primary Completion

March 15, 2022

Study Completion

June 1, 2022

Last Updated

July 28, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share

Individual data will not be shared. But the final results of anonomysed individuals will be shared

Locations